Comparison of OSTAP, ESP Block,Injection of Local Anesthetic to Trocar Insertion for Elective Laparoscopic Cholecystectomy

Sponsor
Diskapi Yildirim Beyazit Education and Research Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT03719157
Collaborator
(none)
100
1
4
6
16.6

Study Details

Study Description

Brief Summary

Main purpose of this prospective single center randomized study is to compare the analgesic effect of ultrasound guided Unilateral Oblique Subcostal Transversus Abdominis Plane (TAP),unilateral Erector Spinae Plane (ESP) blocks and Port site infiltration of local anesthetic in subjects undergoing laparoscopic cholecystectomy. Total 100 patients, American society of anaesthesiology physical status I-II aged between 18-65 who underwent laparoscopic cholecystectomy will recruit to the study.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Unilateral ESP Block
  • Procedure: Unilateral OSTAP Block
  • Procedure: Injection of Local Anesthetic to Trocar Insertion
  • Drug: intravenous patient controlled analgesia
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Comparison of OSTAP, ESP Block,Injection of Local Anesthetic to Trocar Insertion for Elective Laparoscopic Cholecystectomy
Actual Study Start Date :
Apr 1, 2019
Actual Primary Completion Date :
Sep 1, 2019
Actual Study Completion Date :
Oct 1, 2019

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Unilateral ESP Block

Before general anaesthesia, Ultrasound guided unilateral ESP block will perform with 15 ml of 0.5% bupivacaine and 5 ml 2% lidocaine.Patient controlled analgesia (PCA) with tramadol will apply to the all patients. Postoperative pain assessment and opioid consumption will record till the postoperative 24 th hours.

Procedure: Unilateral ESP Block
USG guided ESP block will perform unilateral with Bupivacaine and Lidocain mixture

Drug: intravenous patient controlled analgesia
All patients were followed using a standardized postoperative analgesia protocol which includes tramadol PCA. Tramadol at a concentration of 5 mg/mL is included in our PCA protocol (total volume 100 mL.) PCAs were set to no basal infusion and 10 mg bolus doses with a 20 min lock time.

Active Comparator: Unilateral OSTAP block

Under general anaesthesia, Ultrasound guided unilateral OSTAP block will perform with 15 ml of 0.5% bupivacaine and 5 ml 2% lidocaine.Patient controlled analgesia (PCA) with tramadol will apply to the all patients. Postoperative pain assessment and opioid consumption will record till the postoperative 24 th hours.

Procedure: Unilateral OSTAP Block
USG guided OSTAP block will perform unilateral with Bupivacaine and Lidocain mixture

Drug: intravenous patient controlled analgesia
All patients were followed using a standardized postoperative analgesia protocol which includes tramadol PCA. Tramadol at a concentration of 5 mg/mL is included in our PCA protocol (total volume 100 mL.) PCAs were set to no basal infusion and 10 mg bolus doses with a 20 min lock time.

Active Comparator: Injection of Local Anesthetic to Trocar Insertion

After the laparoscopic surgery was completed, the trocar incision sites were closed. Following the infiltration rules, local anesthetic (15 ml of 0.5% bupivacaine and 5 ml 2% lidocaine) was applied to the trocar sites of skin, fascia, muscle, and preperitoneal area by the surgical team after the operation. A total of 20 mL of local anesthetic was used, with 6 mL for trocar sites of 10 mm, and 4 mL for trocar sites of 5 mm .Patient controlled analgesia (PCA) with tramadol will apply to the all patients. Postoperative pain assessment and opioid consumption will record till the postoperative 24 th hours.

Procedure: Injection of Local Anesthetic to Trocar Insertion
Bupivacaine infiltration will be performed at the end of the surgical procedure to trocar insertion sites.

Drug: intravenous patient controlled analgesia
All patients were followed using a standardized postoperative analgesia protocol which includes tramadol PCA. Tramadol at a concentration of 5 mg/mL is included in our PCA protocol (total volume 100 mL.) PCAs were set to no basal infusion and 10 mg bolus doses with a 20 min lock time.

Sham Comparator: multimodal analgesia

Perioperative and postoperative routine analgesic protocol will be performed with no additional regional anesthesia method.Patient controlled analgesia (PCA) with tramadol will apply to the all patients. Postoperative pain assessment and opioid consumption will record till the postoperative 24 th hours.

Drug: intravenous patient controlled analgesia
All patients were followed using a standardized postoperative analgesia protocol which includes tramadol PCA. Tramadol at a concentration of 5 mg/mL is included in our PCA protocol (total volume 100 mL.) PCAs were set to no basal infusion and 10 mg bolus doses with a 20 min lock time.

Outcome Measures

Primary Outcome Measures

  1. Postoperative opioid consumption [24 hours]

    Patient controlled analgesia (PCA) will provide with tramadol PCA. Total tramadol consumption will calculate and record till the postoperative 24th hours.

  2. Postoperative pain scores: NRS [24 hours]

    Postoperative pain assessment will apply with numerical rating scale. These scores will record till the postoperative 24 th hours.

Secondary Outcome Measures

  1. postoperative nause and vomiting [24 hours]

    The patient with nausea and vomiting will be recorded.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • ASA Status 1-2 patients Exclusion criteria

  • Patients with a body mass index (BMI) of >40kg/m2

  • ASA score of >III

  • Previous abdominal surgery

  • Pregnant or breastfeeding patients

  • Patients with coagulopathy

  • Known local anesthetic allergy

  • infection at the injection site

Contacts and Locations

Locations

Site City State Country Postal Code
1 Diskapi education and research hospital Ankara Turkey 06010

Sponsors and Collaborators

  • Diskapi Yildirim Beyazit Education and Research Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Burak Nalbant, Assistant Doctor, Diskapi Yildirim Beyazit Education and Research Hospital
ClinicalTrials.gov Identifier:
NCT03719157
Other Study ID Numbers:
  • 1
First Posted:
Oct 25, 2018
Last Update Posted:
Jan 11, 2021
Last Verified:
Jan 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 11, 2021